Colorectal Cancer Is Rising in Younger Adults: What the New 2026 U.S. Numbers Mean

The biggest takeaway from the new 2026 U.S. colorectal cancer statistics is simple: this disease is still more common in older adults, but younger adults are making up a growing share of cases, and that changes what patients, families, and primary care clinicians need to pay attention to.

The new numbers show progress and concern at the same time. In adults ages 20 to 49, colorectal cancer incidence rose 3% per year from 2013 to 2022. In adults ages 50 to 64, it rose 0.4% per year. In adults 65 and older, it fell 2.5% per year. Death rates also split by age: they rose about 1% per year in adults under 50 and in adults 50 to 64, while continuing to fall in adults 65 and older.

That does not mean colorectal cancer is suddenly common in young adults. It does mean age alone is becoming a less reassuring reason to dismiss symptoms, delay evaluation, or assume screening can wait without a conversation.

What the 2026 report actually is

This new report is a colorectal cancer statistics review based on U.S. cancer registry and mortality surveillance data. That makes it strong for tracking patterns over time: who is being diagnosed, which age groups are changing, and which groups are seeing more deaths or fewer deaths.

But it is not the kind of study that can tell us why colorectal cancer is rising in younger adults. It cannot prove that any one cause, such as diet, weight, processed food, the microbiome, antibiotics, or sedentary time, is responsible. Researchers are studying those questions, but the current report is descriptive, not causal.

The split trend in plain English

For many older adults, colorectal cancer prevention and earlier detection appear to be helping. Screening has expanded, treatment has improved, and both diagnosis and death rates have continued to move down in the 65-and-older group.

In younger adults, the picture is different. The American Cancer Society reports that nearly half of all new colorectal cancer diagnoses now occur in adults younger than 65. That is a major shift from past decades.

The younger-adult trend also matters because many cases are not being found early. In adults under 50, three out of four diagnoses are already regional or distant stage, meaning the cancer has spread beyond where it started. More than one in four are already distant stage. On top of that, half of colorectal cancers diagnosed before age 50 occur in people ages 45 to 49, a group that is already eligible for routine screening.

Why this matters for everyday readers right now

The practical message is not that everyone should panic. It is that people should stop assuming they are too young for colorectal cancer to even be part of the conversation.

If you are 45 or older and at average risk, screening is supposed to be on your radar now. If you are younger than 45 but have symptoms or higher-risk medical or family history, it is worth asking whether you need earlier evaluation.

This matters for families, too. A partner, parent, sibling, or adult child may be the person who notices recurring rectal bleeding, unexplained tiredness, or bowel changes being brushed off as stress, hemorrhoids, or diet. The right response is not to assume cancer. The right response is to get it checked.

Symptoms that should not be brushed off

Official symptom guidance is straightforward. Symptoms that deserve medical attention include:

Rectal bleeding or blood in or on the stool
A lasting change in bowel habits, including diarrhea, constipation, or feeling that the bowel does not empty all the way
Abdominal pain, aches, or cramps that do not go away
Unexplained weight loss
Stools that become noticeably narrower than usual
Fatigue or iron-deficiency anemia without a clear explanation

These symptoms can be caused by many conditions other than cancer. But being young is not a good reason to ignore them, especially if they are persistent, keep coming back, or happen along with a family history of colorectal cancer or advanced polyps.

Screening starts at 45 for average-risk adults

For adults at average risk, regular colorectal cancer screening now starts at age 45. Colonoscopy is one option, but it is not the only one. Screening can also involve stool-based tests, and some people may be offered other exams such as CT colonography or sigmoidoscopy.

The best screening test is usually the one a person is willing and able to complete on schedule. What matters is being screened and completing any needed follow-up. If a stool-based test or another non-colonoscopy test comes back abnormal, a follow-up colonoscopy is usually needed.

Some people should start earlier than 45 and may need screening more often. Higher-risk groups include people with:

A parent, sibling, or child with colorectal cancer
A family history of advanced polyps
Inherited syndromes such as Lynch syndrome or familial adenomatous polyposis
Inflammatory bowel disease
A personal history of advanced polyps

If any of those apply to you, do not assume the age-45 rule is your rule. Ask what timeline fits your risk.

It is also worth asking about cost before testing. Coverage for recommended screening is often broad, but out-of-pocket charges can still vary, especially when follow-up colonoscopy after an abnormal screening test is billed as diagnostic rather than preventive.

Why access is still a major public-health problem

The newer screening age has not automatically translated into high screening rates. In 2022, only 61.4% of U.S. adults ages 45 to 75 were up to date with colorectal cancer screening. Among adults ages 45 to 49, only 29.8% were up to date. Nearly two-thirds of adults in that 45-to-49 group had never been screened.

That gap matters because half of under-50 diagnoses happen in people ages 45 to 49. In other words, many people who are now eligible for screening still are not getting it.

Screening uptake was higher among people who had health insurance, a personal doctor, and a recent routine checkup. That means access problems are not abstract. They include missed preventive visits, lack of paid time off, transportation barriers, rural access issues, and confusion about test choices or coverage.

The National Cancer Institute has specifically targeted outreach to racially and ethnically diverse communities and rural communities, where screening access and follow-through may be harder. That is an important reminder that the younger-adult trend is not only a medical issue. It is also a health access issue.

What we still do not know

The rise in younger-adult colorectal cancer is real, but the cause is still uncertain. Readers should be cautious about headlines or social posts that blame one food, one chemical exposure, one medication class, or one lifestyle habit as the established explanation. That is not what the evidence shows.

The current report tells us the pattern is changing. It does not settle the cause.

What this means for readers

If you are at average risk, colorectal cancer screening starts at age 45.
If you have rectal bleeding, persistent bowel changes, belly pain, unexplained weight loss, unusual fatigue, or unexplained anemia, do not assume you are too young for colorectal cancer to be considered.
If a close family member had colorectal cancer or advanced polyps, ask whether you need screening before 45.
If you are due for screening, a routine primary care visit is a good time to ask which test fits your risk, schedule, and insurance situation.

The calm bottom line is this: know your symptoms, know your family history, and do not let age alone delay screening or evaluation.

Sources

This article is for general informational purposes only and is not medical advice. Research findings can be early, limited, or subject to change as new evidence emerges. For personal guidance, diagnosis, or treatment, consult a licensed clinician. For current outbreak or public health guidance, follow your local health department, the CDC, or another relevant public health authority.